Literature DB >> 188506

Cyclic AMP in the CSF of patients with schizophrenia.

J Biederman, R Rimon, R Ebstein, R H Belmaker, J T Davidson.   

Abstract

The dopamine hypothesis of schizophrenia proposes that schizophrenia is associated with increased brain dopaminergic function. Because dopamine is thought to stimulate the production of cyclic AMP in the brain, we hypothesized that CSF cyclic AMP would be increased in schizophrenia. Cyclic AMP in the CSF was determined in 19 schizophrenic patients who had not received neuroleptic treatment in the preceding two weeks. No significant difference could be shown between CSF cyclic AMP in these patients and CSF cyclic AMP in 10 psychiatrically normal controls.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 188506     DOI: 10.1192/bjp.130.1.64

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  4 in total

1.  Cerebrospinal fluid cyclic AMP and acid monoamine metabolites following probenecid: studies in psychiatric patients.

Authors:  M B Bowers; R E Study
Journal:  Psychopharmacology (Berl)       Date:  1979-03-29       Impact factor: 4.530

2.  Effect of adjuvant reserpine treatment on catecholamine metabolism in schizophrenic patients under long-term neuroleptic treatment.

Authors:  G Bagdy; A Perenyi; E Frecska; A Seregi; M I Fekete; L Tothfalusi; K Magyar; A Bela; M Arato
Journal:  J Neural Transm       Date:  1988       Impact factor: 3.575

3.  The effect of L-dopa and propranolol on human CSF cyclic nucleotides.

Authors:  R H Belmaker; R P Ebstein; J Biederman; R Stern; M Berman; H M van Praag
Journal:  Psychopharmacology (Berl)       Date:  1978-07-19       Impact factor: 4.530

4.  Cyclic GMP in the CSF of patients with schizophrenia before and after neuroleptic treatment.

Authors:  R P Ebstein; J Biederman; R Rimon; J Zohar; R H Belmaker
Journal:  Psychopharmacology (Berl)       Date:  1976-12-21       Impact factor: 4.530

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.